HSV-1 ICP4 Immediate Early Protein Activators
HSV-1 ICP4 Immediate Early Protein Activators are chemical entities that indirectly enhance the activity of ICP4 through multifaceted pathways predominantly associated with DNA replication and repair. Acyclovir monophosphate, Valacyclovir, Ganciclovir triphosphate, Trifluridine triphosphate, Cidofovir, Tenofovir, and Penciclovir triphosphate, all nucleoside or nucleotide analogs, after being metabolically activated and incorporated into the viral DNA, stimulate cellular DNA damage responses. These responses are critical for ICP4's function, as the protein utilizes these pathways to initiate and regulate the transcription of viral genes, effectively turning the antiviral mechanism of these drugs into an indirect activation signal for itself. Similarly, Foscarnet, by inhibiting viral DNA polymerase, induces DNA replication stress, which can lead to the activation of DNA repair pathways, again providing an avenue for ICP4 to potentiate its transcriptional regulatory functions.
Beyond nucleotide analogs, other compounds like Forskolin and Phorbol 12-myristate 13-acetate (PMA) engage with signaling pathways that can modulate ICP4's activity. Forskolin, by increasing intracellular cAMP levels, activates PKA signaling, potentially phosphorylating proteins that interact with ICP4 and thus modulating its transcriptional activity. PMA, on the other hand, acts as a PKC activator and may enhance ICP4 function by phosphorylation of substrates that influence ICP4's regulatory role, leading to increased viral gene transcription. Additionally, calcium ionophores like Ionomycin and A23187 elevate intracellular calcium levels, thereby initiating calcium-dependent signaling cascades. These cascades can indirectly influence the regulatory effects of ICP4 on viral gene expression, showcasing the diverse molecular mechanisms through which these activators can enhance the functional activity of HSV-1 ICP4 Immediate Early Protein without the need for direct protein interaction or upregulation of expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acyclovir | 59277-89-3 | sc-202906 sc-202906A | 50 mg 500 mg | $150.00 $940.00 | 2 | |
Acyclovir monophosphate, upon phosphorylation, can mimic nucleotides and indirectly enhance ICP4 activity by being incorporated into viral DNA and subsequently causing DNA chain termination, which may activate DNA damage response pathways that ICP4 leverages for initiating transcription of viral genes. | ||||||
Valacyclovir Hydrochloride | 124832-27-5 | sc-204937 sc-204937A | 50 mg 100 mg | $119.00 $153.00 | ||
Valacyclovir, a prodrug of acyclovir, after being converted into its active form, can elevate ICP4 activity in a similar mechanism as acyclovir monophosphate by activating DNA damage response pathways that are utilized by ICP4 for the transcription of viral genes. | ||||||
Ganciclovir | 82410-32-0 | sc-203963 sc-203963A | 50 mg 250 mg | $233.00 $421.00 | 1 | |
Ganciclovir triphosphate acts as a guanine nucleoside analog that can be incorporated into viral DNA and potentially amplify ICP4 activity by activating DNA repair and synthesis pathways that ICP4 exploits to enhance its transcriptional regulatory functions. | ||||||
Trifluorothymidine | 70-00-8 | sc-222370 sc-222370A | 100 mg 1 g | $179.00 $500.00 | 1 | |
Trifluridine triphosphate, as a thymidine analog, can be incorporated into DNA and indirectly enhance ICP4 activity by inducing stress on DNA replication processes, thereby activating DNA repair mechanisms that ICP4 can utilize to augment viral gene transcription. | ||||||
Cidofovir | 113852-37-2 | sc-482141 | 50 mg | $135.00 | ||
Cidofovir, a cytosine analog, once phosphorylated, can be incorporated into DNA, potentially enhancing ICP4 function by stimulating DNA damage response pathways, which ICP4 may exploit for its transcriptional activation of viral genes. | ||||||
Tenofovir | 147127-20-6 | sc-204335 sc-204335A | 10 mg 50 mg | $157.00 $646.00 | 11 | |
Tenofovir, when metabolized to its active diphosphate form, can be incorporated into DNA and indirectly increase ICP4 activity by engaging DNA repair pathways which ICP4 may use to upregulate transcription of viral genes. | ||||||
Penciclovir | 39809-25-1 | sc-203183 | 100 mg | $260.00 | ||
Penciclovir triphosphate acts as a guanosine analog and can be incorporated into DNA, potentially enhancing ICP4 activity by triggering DNA repair mechanisms that ICP4 capitalizes on to promote viral gene transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels, which can enhance ICP4 activity indirectly by activating the PKA signaling pathway, potentially leading to the phosphorylation of proteins that interact with ICP4, modulating its transcriptional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which could enhance ICP4 function by phosphorylating substrates that modulate ICP4's transcriptional regulatory role, potentially increasing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin, a calcium ionophore, can increase intracellular calcium levels, potentially enhancing ICP4 activity by activating calcium-dependent signaling pathways that may influence ICP4's regulatory effects on viral gene transcription. | ||||||